Ignite Creation Date:
2024-05-06 @ 12:35 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03790111
Status:
TERMINATED
Last Update Posted:
2023-04-19
First Post:
2018-12-25
Brief Title:
A Safety and Efficacy Study of XERMELO First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer
Sponsor:
TerSera Therapeutics LLC
Organization:
TerSera Therapeutics LLC
Organization Data
Organization:
TerSera Therapeutics LLC
Class:
INDUSTRY
Study ID:
LX16061-207-BTC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
TerSera Therapeutics LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None